Bifidobacterium animalis subsp. lactis LKM512 reduces levels of intestinal trimethylamine produced by intestinal microbiota in healthy volunteers: A double-blind, placebo-controlled study
Previous clinical studies on the prevention of atherosclerosis with probiotics aimed only for the reduction of blood lipids. The aim of this study was to investigate the effect of probiotic Bifidobacterium animalis subsp. lactis LKM512 on colonic trimethylamine (TMA) and atherosclerosis-related mark...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-09-01
|
| Series: | Journal of Functional Foods |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464617303493 |